Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Lister

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
British Journal of Haematology|March 4, 2006
Development of a quantitative real-time polymerase chain reaction method for monitoring CEBPA mutations in normal karyotype acute myeloid leukaemiaLan-Lan Smith, Daniel Pearce, Matthew L Smith, et al.
Genes, Chromosomes & Cancer|April 16, 2003
Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion eventsSilvana Debernardi, Debra M Lillington, Tracy Chaplin, et al.
Cancer Research|March 17, 2007
The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell linesSandra J Strauss, Karen Higginbottom, Simone Jüliger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2014
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classificationBruce D Cheson, Richard I Fisher, Sally F Barrington, et al.
Haematologica|November 26, 2008
Clinical relevance of MDM2 SNP 309 and TP53 Arg72Pro in follicular lymphomaDavid Wrench, Rachel Waters, Emanuela Carlotti, et al.
Cancer Research|February 8, 2005
Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemiasManoj Raghavan, Debra M Lillington, Spyros Skoulakis, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|October 23, 2002
Acute myelogenous leukaemia in older patients at St Bartholomew's Hospital: outcome with mitoxantrone and cytarabineChristopher D Dalley, Deborah L Lillington, Michael Bradburn, et al.
Histopathology|May 13, 2010
The expression of Bcl-2 by proliferating cells varies in different categories of B-cell lymphomaNoraidah Masir, Margaret Jones, Abigail M Lee, et al.
British Journal of Haematology|January 10, 2012
Early relapse and refractory disease remain risk factors in the anthracycline and autologous transplant era for patients with relapsed/refractory classical Hodgkin lymphoma: a single centre intention-to-treat analysisPaul Greaves, Andrew Wilson, Janet Matthews, et al.
British Journal of Haematology|August 30, 2002
Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemiaEmanuela Carlotti, Francesca Pettenella, Ricardo Amaru, et al.
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
British Journal of Haematology|March 4, 2006
Development of a quantitative real-time polymerase chain reaction method for monitoring CEBPA mutations in normal karyotype acute myeloid leukaemiaLan-Lan Smith, Daniel Pearce, Matthew L Smith, et al.
Genes, Chromosomes & Cancer|April 16, 2003
Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion eventsSilvana Debernardi, Debra M Lillington, Tracy Chaplin, et al.
Cancer Research|March 17, 2007
The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell linesSandra J Strauss, Karen Higginbottom, Simone Jüliger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2014
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classificationBruce D Cheson, Richard I Fisher, Sally F Barrington, et al.
Haematologica|November 26, 2008
Clinical relevance of MDM2 SNP 309 and TP53 Arg72Pro in follicular lymphomaDavid Wrench, Rachel Waters, Emanuela Carlotti, et al.
Cancer Research|February 8, 2005
Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemiasManoj Raghavan, Debra M Lillington, Spyros Skoulakis, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|October 23, 2002
Acute myelogenous leukaemia in older patients at St Bartholomew's Hospital: outcome with mitoxantrone and cytarabineChristopher D Dalley, Deborah L Lillington, Michael Bradburn, et al.
Histopathology|May 13, 2010
The expression of Bcl-2 by proliferating cells varies in different categories of B-cell lymphomaNoraidah Masir, Margaret Jones, Abigail M Lee, et al.
British Journal of Haematology|January 10, 2012
Early relapse and refractory disease remain risk factors in the anthracycline and autologous transplant era for patients with relapsed/refractory classical Hodgkin lymphoma: a single centre intention-to-treat analysisPaul Greaves, Andrew Wilson, Janet Matthews, et al.
British Journal of Haematology|August 30, 2002
Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemiaEmanuela Carlotti, Francesca Pettenella, Ricardo Amaru, et al.
Pageof 12